Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women

Wenyi Qin, Weizhu Zhu, Huidong Shi, John E. Hewett, Rachel L. Ruhlen, Ruth S. MacDonald, George E. Rottinghaus, Yin Chieh Chen, Edward R. Sauter

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

We determined if soy isoflavones have dose-related estrogenic and methylation effects. Thirty-four healthy premenopausal women were randomized to 40 mg or 140 mg isoflavones daily through one menstrual cycle. Breast specific and systemic estrogenic effects were assessed measuring the estrogenic marker complement (C)3 and changes in cytology, whereas methylation assessment of 5 cancer related genes (p16, RASSF1A, RARβ2, ER, and CCND2) was performed on intraductal specimens. Serum genistein significantly increased after consuming both isoflavone doses. Cytology did not significantly change at either isoflavone dose. Serum C3 levels posttreatment were inversely related to change in serum genistein (r =-0.76, P = 0.0045) in women consuming low but not high dose isoflavones. The RARβ2 hypermethylation increase posttreatment correlated with the posttreatment genistein level considering the entire group (r = 0.67, P = 0.0017) and those receiving high-dose isoflavones (r = 0.68, P = 0.021). At the low but not the high isoflavone dose, CCND2 hypermethylation increase correlated with posttreatment genistein levels (r = 0.79, P = 0.011). In summary, the inverse correlation between C3 and genistein suggests an antiestrogenic effect. Isoflavones induced dose-specific changes in RARβ2 and CCND2 gene methylation, which correlated with genistein levels. This work provides novel insights into estrogenic and methylation effects of dietary isoflavones.

Original languageEnglish (US)
Pages (from-to)238-244
Number of pages7
JournalNutrition and Cancer
Volume61
Issue number2
DOIs
StatePublished - Mar 1 2009

Fingerprint

Isoflavones
Breast
Genistein
Methylation
Estrogens
Cell Biology
Serum
Complement C3
Neoplasm Genes
Menstrual Cycle

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Oncology
  • Nutrition and Dietetics
  • Cancer Research

Cite this

Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women. / Qin, Wenyi; Zhu, Weizhu; Shi, Huidong; Hewett, John E.; Ruhlen, Rachel L.; MacDonald, Ruth S.; Rottinghaus, George E.; Chen, Yin Chieh; Sauter, Edward R.

In: Nutrition and Cancer, Vol. 61, No. 2, 01.03.2009, p. 238-244.

Research output: Contribution to journalArticle

Qin, W, Zhu, W, Shi, H, Hewett, JE, Ruhlen, RL, MacDonald, RS, Rottinghaus, GE, Chen, YC & Sauter, ER 2009, 'Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women', Nutrition and Cancer, vol. 61, no. 2, pp. 238-244. https://doi.org/10.1080/01635580802404196
Qin, Wenyi ; Zhu, Weizhu ; Shi, Huidong ; Hewett, John E. ; Ruhlen, Rachel L. ; MacDonald, Ruth S. ; Rottinghaus, George E. ; Chen, Yin Chieh ; Sauter, Edward R. / Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women. In: Nutrition and Cancer. 2009 ; Vol. 61, No. 2. pp. 238-244.
@article{24a0d28547034b8c8bf8d676013e1564,
title = "Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women",
abstract = "We determined if soy isoflavones have dose-related estrogenic and methylation effects. Thirty-four healthy premenopausal women were randomized to 40 mg or 140 mg isoflavones daily through one menstrual cycle. Breast specific and systemic estrogenic effects were assessed measuring the estrogenic marker complement (C)3 and changes in cytology, whereas methylation assessment of 5 cancer related genes (p16, RASSF1A, RARβ2, ER, and CCND2) was performed on intraductal specimens. Serum genistein significantly increased after consuming both isoflavone doses. Cytology did not significantly change at either isoflavone dose. Serum C3 levels posttreatment were inversely related to change in serum genistein (r =-0.76, P = 0.0045) in women consuming low but not high dose isoflavones. The RARβ2 hypermethylation increase posttreatment correlated with the posttreatment genistein level considering the entire group (r = 0.67, P = 0.0017) and those receiving high-dose isoflavones (r = 0.68, P = 0.021). At the low but not the high isoflavone dose, CCND2 hypermethylation increase correlated with posttreatment genistein levels (r = 0.79, P = 0.011). In summary, the inverse correlation between C3 and genistein suggests an antiestrogenic effect. Isoflavones induced dose-specific changes in RARβ2 and CCND2 gene methylation, which correlated with genistein levels. This work provides novel insights into estrogenic and methylation effects of dietary isoflavones.",
author = "Wenyi Qin and Weizhu Zhu and Huidong Shi and Hewett, {John E.} and Ruhlen, {Rachel L.} and MacDonald, {Ruth S.} and Rottinghaus, {George E.} and Chen, {Yin Chieh} and Sauter, {Edward R.}",
year = "2009",
month = "3",
day = "1",
doi = "10.1080/01635580802404196",
language = "English (US)",
volume = "61",
pages = "238--244",
journal = "Nutrition and Cancer",
issn = "0163-5581",
publisher = "Routledge",
number = "2",

}

TY - JOUR

T1 - Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women

AU - Qin, Wenyi

AU - Zhu, Weizhu

AU - Shi, Huidong

AU - Hewett, John E.

AU - Ruhlen, Rachel L.

AU - MacDonald, Ruth S.

AU - Rottinghaus, George E.

AU - Chen, Yin Chieh

AU - Sauter, Edward R.

PY - 2009/3/1

Y1 - 2009/3/1

N2 - We determined if soy isoflavones have dose-related estrogenic and methylation effects. Thirty-four healthy premenopausal women were randomized to 40 mg or 140 mg isoflavones daily through one menstrual cycle. Breast specific and systemic estrogenic effects were assessed measuring the estrogenic marker complement (C)3 and changes in cytology, whereas methylation assessment of 5 cancer related genes (p16, RASSF1A, RARβ2, ER, and CCND2) was performed on intraductal specimens. Serum genistein significantly increased after consuming both isoflavone doses. Cytology did not significantly change at either isoflavone dose. Serum C3 levels posttreatment were inversely related to change in serum genistein (r =-0.76, P = 0.0045) in women consuming low but not high dose isoflavones. The RARβ2 hypermethylation increase posttreatment correlated with the posttreatment genistein level considering the entire group (r = 0.67, P = 0.0017) and those receiving high-dose isoflavones (r = 0.68, P = 0.021). At the low but not the high isoflavone dose, CCND2 hypermethylation increase correlated with posttreatment genistein levels (r = 0.79, P = 0.011). In summary, the inverse correlation between C3 and genistein suggests an antiestrogenic effect. Isoflavones induced dose-specific changes in RARβ2 and CCND2 gene methylation, which correlated with genistein levels. This work provides novel insights into estrogenic and methylation effects of dietary isoflavones.

AB - We determined if soy isoflavones have dose-related estrogenic and methylation effects. Thirty-four healthy premenopausal women were randomized to 40 mg or 140 mg isoflavones daily through one menstrual cycle. Breast specific and systemic estrogenic effects were assessed measuring the estrogenic marker complement (C)3 and changes in cytology, whereas methylation assessment of 5 cancer related genes (p16, RASSF1A, RARβ2, ER, and CCND2) was performed on intraductal specimens. Serum genistein significantly increased after consuming both isoflavone doses. Cytology did not significantly change at either isoflavone dose. Serum C3 levels posttreatment were inversely related to change in serum genistein (r =-0.76, P = 0.0045) in women consuming low but not high dose isoflavones. The RARβ2 hypermethylation increase posttreatment correlated with the posttreatment genistein level considering the entire group (r = 0.67, P = 0.0017) and those receiving high-dose isoflavones (r = 0.68, P = 0.021). At the low but not the high isoflavone dose, CCND2 hypermethylation increase correlated with posttreatment genistein levels (r = 0.79, P = 0.011). In summary, the inverse correlation between C3 and genistein suggests an antiestrogenic effect. Isoflavones induced dose-specific changes in RARβ2 and CCND2 gene methylation, which correlated with genistein levels. This work provides novel insights into estrogenic and methylation effects of dietary isoflavones.

UR - http://www.scopus.com/inward/record.url?scp=61649113446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61649113446&partnerID=8YFLogxK

U2 - 10.1080/01635580802404196

DO - 10.1080/01635580802404196

M3 - Article

VL - 61

SP - 238

EP - 244

JO - Nutrition and Cancer

JF - Nutrition and Cancer

SN - 0163-5581

IS - 2

ER -